Hemostasis and thyroid diseases revisited

Journal of Endocrinological Investigation

Volumn 27, Issue 9, 2004, Pages 886-892

  Franchini, Massimo ^a  

^a UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

Author keywords

Bleeding; Hemostasis; Hyperthyroidism; Hypothyroidism; Thrombosis; Thyroid

Indexed keywords

ADRENALIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; CARDIOLIPIN ANTIBODY; COLLAGEN; CYCLOPHOSPHAMIDE; D DIMER; DESMOPRESSIN; ERYTHROPOIETIN; FIBRINOPEPTIDE A; HOMOCYSTEINE; LEVOTHYROXINE; METHYLPREDNISOLONE; PREKALLIKREIN; RISTOCETIN; THYROID HORMONE; VON WILLEBRAND FACTOR; WARFARIN;

ANTICOAGULATION; ANTIGEN ANTIBODY REACTION; ANTIPHOSPHOLIPID SYNDROME; BLEEDING TIME; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING TEST; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DRUG MEGADOSE; FIBRINOLYSIS; GRAVES DISEASE; HASHIMOTO DISEASE; HEMOPHILIA A; HEMOSTASIS; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; METASTASIS; MUCOSAL BLEEDING; PAPILLARY CARCINOMA; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; PUERPERIUM; REVIEW; RISK FACTOR; SUBSTITUTION THERAPY; SYMPTOMATOLOGY; THROMBOCYTE COUNT; THROMBOCYTE LIFESPAN; THROMBOCYTOPENIC PURPURA; THROMBOEMBOLISM; THYROID CANCER; THYROIDECTOMY; VASCULAR DISEASE; VON WILLEBRAND DISEASE;

EID: 14544302357     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346287     Document Type: Review

References (89)

1. Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 1965, 273: 1057-61.
2. Myrup B, Bregengård C, Faber J. Primary haemostasis and thyroid disease. J Intern Med 1995, 238: 59-63.
3. Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997, 136: 1-7.
4. Rennie JA, Bewsher PD, Murchison LE, Ogston E. Coagulation and fibrinolysis in thyroid disease. Acta Haematol 1978, 58: 171-7.
5. Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgrad Med J 1990, 66: 280-4.
6. Erem C, Kavgaci H, Ersöz H, et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 2003, 57: 78-81.
7. Savage RA, Sipple C. Marrow myxedema. Arch Pathol Lab Med 1975, 111: 375-7.
8. Berchtold P, Harris JP, Tani P, Piro L, McMillan R. Autoantibodies to platelet glycoproteins in patients with disease-related immune thrombocytopenia. Br J Haematol 1989, 73: 365-8.
9. Zeigler ZR, Hasiba U, Lewis JH, Vagnucci AH, West VA, Bezek EA. Hemostatic defects in response to aspirin challenge in hypothyroidism. Am J Hematol 1986, 17: 209-15.
10. Hellem AJ, Segaard E, Solem JH. The adhesiveness of human blood platelets and thyroid function. Acta Med Scand 1975, 197: 15-7.
11. Edson JR, Fecher DR, Doe RP. Low platelet adhesiveness and other abnormalities in hypothyroidism. Ann Intern Med 1975, 82: 342-6.
12. Palareti G, Biagi G, Legnani C, et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 1989, 62: 1053-6.
13. Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982, 97: 713-6.
14. Rogers JS, Shane SR. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983, 102: 444-9.
15. Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987, 1: 1007-9.
16. Smith SR, Anger MJ. Hypothyroidism and von Willebrand's disease. Lancet 1987, 1: 1314.
17. MacCallum PK, Rodgers M, Taberner DA. Hypothyroidism and von Willebrand's disease. Lancet 1987, 1: 1314.
18. Thornton JG, Parapia LA, Minford AMB. Hypothyroidism and von Willebrand's disease. Lancet 1987, 1: 1314-5.
19. Nitu-Whalley IC, Lee CA. Acquired von Willebrand syndrome - report of 10 cases and review of the literature. Haemophilia 1999, 5: 318-26.
20. Michiels JJ, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001, 7: 113-5.
21. Franchini M, de Gironcoli M, Lippi G, et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haematologica 2002, 8: 142-4.
22. Petrini P. Acquired von Willebrand disease. Haemophilia 1999, 5 (Suppl 2): 68-9.
23. Attivissimo LA, Lichtman SM, Klein I. Acquired von Willebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid 1995, 5: 399-401.
24. Blesing NE, Hambley H, McDonald GA. Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia. Postgrad Med J 1990, 66: 474-6.
25. Bruggers CS, McElligott K, Rallison ML. Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy. J Paediatr 1994, 125: 911-3.
26. Levesque H, Borg JY, Cailleux N, et al. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Eur J Med 1993, 2: 287-8.
27. Rinder MR, Richard RE, Rinder HM. Acquired von Willebrand's disease: a concise review. Am J Hematol 1997, 54: 139-45.
28. Aylesworth C, Smallridge RC, Rick ME, Alving BM. Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis. Am J Hematol 1995, 50: 217-9.
29. Tjan-Heijnen VCG, Harthoorn-Lasthuizen EJ, Kurstjens RMA, Koolen MI. A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease. Neth J Med 1994, 44: 91.
30. Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 2001, 7: 523-5.
31. Graninger W, Pirich KR, Speiser W, Deutsch E, Waldhäusl WK. Effect of thyroid hormones on plasma protein concentration in man. J Clin Endocrinol Metab 1986, 63: 407-11.
32. Erfuth EM, Ericsson U-B, Egervall K, Lethagen SR. Effect of desmopressin and long-term thyroxine replacement on haemostasis in hypothyroidism. Clin Endocrinol (Oxf) 1995, 42: 373-8.
33. Van Oosterom AT, Kerkhoven P, Veltkamp JJ. Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man. Thromb Haemost 1979, 41: 273-85.
34. De Feo P. Hormonal regulation of human protein metabolism. Eur J Endocrinol 1996, 135: 7-18.
35. Egeberg BO. Influence of thyroid function on the blood clotting system. Scand J Clin Lab Invest 1963, 15: 1-7.
36. Nordoy A, Vikmo H, Berntsen H. Haemostatic and lipid abnormalities in hypothyroidism. Scand J Haematol 1976, 16: 154-60.
37. Müller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk for vascular or thrombotic disease. Eur J Clin Invest 2001, 31: 131-7.
38. Marongiu F, Biondi G, Conti M, et al. Is a hypercoagulable state present in hypothyroidism? Thromb Haemost 1992, 67: 729.
39. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 2000, 132: 270-8.
40. Chadaverian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998, 79: 99-103.
41. Fowkes FGR, Lowe GDO, Housley E, et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993, 342: 84-6.
42. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995, 322: 635-41.
43. Chadaverian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001, 86: 732-7.
44. Özcan MA, Çömlekçi A, Demrkan F, et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb Res 2003, 110: 243-7.
45. Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid 1999; 9: 1163-6.
46. Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thromb Haemost 1976; 35: 415-22.
47. Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E. Activation of blood coagulation in Graves' disease. Horm Metab Res 1991, 23: 609-11.
48. Erem C, Ersöz H, Karti SS, et al. Blood coagulation and fibrinolysis in hyperthyroidism. J Endocrinol Invest 2002, 25: 345-50.
49. Hymes K, Blum M, Lackner H, Karpatkin S. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med 1981, 94: 27-30.
50. Lamberg BA, Kivikangas V, Pelkonen R. Thrombocytopenia and decreased life-span of thrombocytes in hyperthyroidism Ann Clin Res 1971, 3: 98-102.
51. Marshall JS, Weisberger AS, Levy RP. Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann Intern Med 1967, 67: 411-4.
52. Kurata Y, Nishioeda Y, Tsubakio T, Kitani T. Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. Acta Haematol 1980, 63: 185-90.
53. Panzer S, Haubenstock A, Minar E. Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111Indium labeled platelet kinetics and platelet associated immunoglobulins G and M. J Clin Endocrinol Metab 1990, 70: 491-6.
54. Bizzaro N. Familial association of autoimmune thrombocytopenia and hyperthyroidism. Am J Hematol 1992, 39: 294-8.
55. Adrouny A, Sandler R, Carmel R. Variable presentation of thrombocytopenia in Graves' disease. Arch Intern Med 1982, 142: 1460-4.
56. Pinals RS, Tomar RH, Haas DC, Farah F. Graves' disease, myasthenia gravis and purpura. Ann Intern Med 1977, 87: 250.
57. Yamaguchi K, Ookubo Y, Matsuda H, Suzaki K, Fujushima H, Uzwa H. Idiopathic thrombocytopenic purpura subsequent to Graves' disease and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1987, 3: 233-7.
58. Lio S, Albin M, Girelli G, et al. Abnormal thyroid function test results in patients with Fisher Evans syndrome. J Endocrinol Invest 1993, 16: 163-7.
59. Crabtree GR, Lee JC, Cornwell GG. Autoimmune thrombocytopenic purpura and Hashimoto's thyroiditis. Ann Intern Med 1975, 83: 371-2.
60. Ho SL, Shah M, Williams AC. Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis. Muscle Nerve 1992, 15: 966-7.
61. Segal BM, Weintraub MI. Hashimoto's thyroiditis, myasthenia gravis, idiopathic thrombocytopenic purpura. Ann Intern Med 1976, 85: 761-3.
62. Cordiano I, Betterle C, Spadaccino CA, Soini B, Girolami A, Fabris F. Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol 1998, 113: 373-8.
63. Marongiu F, Conti M, Murtas ML, et al. Anticardiolipin antibodies in Grave's disease: relationship with thrombin activity in vivo. Thromb Res 1991, 64: 745-9.
64. Paggi A, Caccavo D, Ferri GM, et al. Anticardiolipin antibodies in autoimmune thyroid disease. Clin Endocrinol (Oxf) 1994, 40: 329-33.
65. Hofbauer LC, Spitzweg C, Heufelder AE. Graves' disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996, 23: 1435-7.
66. Takahashi A, Tamura A, Ishikawa O. Antiphospholipid antibody syndrome complicated by Graves'disease. J Dermatol 2002, 29: 776-80.
67. Osundeko O, Hasinski S, Rose LI. Anticardiolipin antibodies in Hashimoto's disease. Endocr Pract 2001, 7: 181-3.
68. Dagenais P, Urowitz MB, Gladman DD, Norman CS. A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 1992, 19: 1393-6.
69. Loeliger EA, Esch B. The biological disappearance rate of prothrombin, factors VII, and X from plasma in hypothyroidism, hyperthyroidism, and during fever. Thromb Diathes Haemorrh 1963, 10: 267-77.
70. Kellet HA, Sawers JSA, Boulton FE, Cholerton S, Park BK, Toft AD. Problems of anticoagulation with warfarin in hyperthyroidism. Q Med J 1986, 58: 43-51.
71. Sievert R, Goldstein ML, Surks MI. Graves' disease and autoimmune factor VIII deficiency. Thyroid 1996, 6: 245-7.
72. Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S. Apatehtic Graves' disaese and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 2002, 25: 246-9.
73. De Stefano V, Leone G, Teofili L, et al. Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein deficient Italian family. Thromb Res 1990, 60: 397-404.
74. Kyrle PA, Niessner H, Deutsch E, Lechner K, Korninger C, Mannhalter C. CRM+ severe Fletcher factor deficiency associated with Graves'disease. Haemostasis 1984, 14: 302-6.
75. Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001, 2: 153-60.
76. Liu L, Wang X, Lin Z, Wu H. Elevated plasma levels of vWF: ag in hyperthyroidism are mediated through beta-adrenergic receptors. Endocrine Res 1993, 19: 123-33.
77. Morikawa Y, Morikawa A, Makino I. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Grave's disease: TM a possible new marker of the peripheral activity of thyroid hormones: J Clin Endocrinol Metab 1993, 76: 609-14.
78. Chen YL, Tan J, Wang X, Liang H, Sun X. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur J Clin Invest 1998, 28: 1050-4.
79. Morishita E, Hashimoto T, Asakura H, et al. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves'disease. Thromb Haemost 1998, 79: 919-23.
80. Chadaverian R, Bruckert E, Giral P, Turpin G. Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinol 1999, 10: 481-6.
81. Grant PJ, Medcalf RL. Hormonal regulation of haemostasis and the molecular biology of the fibrinolytic system. Clin Sci (Lond) 1990, 78: 3-11.
82. Marongiu F, Conti M, Mameli G, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 1988, 11: 723-5.
83. Polikar R, Burger AG, Scherrer US, Nicod P. The thyroid and the heart. Circulation 1993, 87: 1435-41.
84. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992, 327: 94-8.
85. Tiede DJ, Tefferi A, Kochhar R, Thompson GB, Hay ID. Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Cancer 1994, 73: 702-5.
86. Raveh E, Cohen M, Shpitzer T, Feinmesser R. Carcinoma of the thyroid: a cause of hypercoagulability? Ear Nose Throat J 1995, 74: 110-2.
87. Sagripanti A, Carpi A, Baicchi U. The measurement of plasma D-dimer in the follow-up after thyroidectomy for cancer: preliminary data. Thyroidology 1991, 3: 31-5.
88. Rosen IB, Anderson I, Musclow CE. The factor of factor XI deficiency in thyroid neoplasia. Surgery 1986, 100: 1062-7.
89. Osterud B, Due J. Blood coagulation in patients with benign and malignant tumors before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol 1984, 32: 258-64.